Erythrocyte-encapsulated L-asparaginase Suspension

Known as: GRASPA 
A suspension of erythrocytes encapsulating L-asparaginase with potential antineoplastic activity. Upon administration of erythrocyte-encapsulated L… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
l-asparaginase, an enzyme originally derived from Escherichia coli, represents a major drug in the treatment of acute… (More)
Is this relevant?
2015
2015
GRASPA 2015 is the biennial conference of the Italian Research Group for Environmental Statistics (GRASPA-SIS). GRASPA is active… (More)
Is this relevant?
2015
2015
PURPOSE The GRASPALL/GRAALL-SA2-2008 Phase II trial evaluated the safety and efficacy of L-asparaginase encapsulated within… (More)
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
2011
2011
l-asparaginase encapsulated within erythrocytes (GRASPA(®) ) should allow serum asparagine depletion over a longer period than… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Is this relevant?
2007
2007
L-asparaginase is an essential drug in the treatment of acute lymphoblastic leukemia (ALL) in cleaving plasmatic asparagine, an… (More)
Is this relevant?
1979
1979
Chaudrons d'epoque archaique, dates par comparaison du VI s. av. J.-C. Probleme du lieu de fabrication. 
Is this relevant?